ArticleTranslational pediatrics2020
Comparative study on the efficacy and safety of low-dose sodium valproate
Article in Translational pediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFebrile convulsion has a serious impact on the health and development of children. Diazepam treatment for febrile convulsion has many adverse reactions, which have a negative impact on the therapeutic effect. Therefore, the present study examined the efficacy and safety of low-dose sodium valproate on the treatment of pediatric patients with febrile convulsion.
methodsFrom August 2016 to August 2019, a total of 110 children who suffered recurrent febrile convulsions were selected for the present study. These children were randomly divided into the observation group and the control group, with 55 children in each group. The control group was given low-dose diazepam therapy, while the observation group received low-dose sodium valproate. The therapeutic effects were compared between the two groups.
resultsThe observation group had a significantly lower effective rate (94.55%) than the control group (74.55%, P<0.05) and significantly shorter antispasmodic time and fever clearance time (11.60±2.08 min and 11.39±1.81 h, respectively) than the control group (16.07±2.89 min and 17.09±3.12 h) (P<0.05). Six months after treatment, the observation group had higher scores on cognitive development indices than the control group, including gross motor skills, language, adaptability, fine motor skills, and social interaction (P<0.05). In addition, the observation group had a significantly lower incidence of adverse reactions and recurrence rate (5.45% and 3.64%, respectively) than the control group (20.00% and 18.18%) (P<0.05).
conclusionsIn the prevention and treatment of pediatric febrile convulsions, low-dose sodium valproate can rapidly relieve the clinical symptoms of children. In addition, this medication exhibits a high safety profile and significantly improves the cognitive ability of the patients. Low-dose sodium valproate has a definite therapeutic effect. Therefore, treatment with low-dose sodium valproate is worth promoting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.